Table of Contents

1 Introduction 6

• 1.1 Industry Definition and Research Scope 6
  • 1.1.1 Industry Definition 6
  • 1.1.2 Research Scope 7
• 1.2 Research Methodology 9
  • 1.2.1 Overview of Market Research Methodology 9
  • 1.2.2 Market Assumption 10
  • 1.2.3 Secondary Data 10
  • 1.2.4 Primary Data 10
  • 1.2.5 Data Filtration and Model Design 11
  • 1.2.6 Market Size/Share Estimation 12
  • 1.2.7 Research Limitations 13
• 1.3 Executive Summary 14

2 Market Overview and Dynamics 16

• 2.1 Market Size and Forecast 16
• 2.2 Major Growth Drivers 17
• 2.3 Market Restraints and Challenges 20
• 2.4 Emerging Opportunities and Market Trends 23
• 2.5 Porter’s Fiver Forces Analysis 26

3 Segmentation of Asia Pacific Market by Product Type 30

• 3.1 Market Overview by Product Type 30
• 3.2 Monitoring ECG Systems 32
  • 3.2.1 Remote Data Monitoring 33
  • 3.2.2 Event Monitoring 34
  • 3.2.3 Continuous Cardiovascular Monitoring Systems 35
• 3.3 Diagnostic ECG Systems 36
  • 3.3.1 Rest ECG Systems 37
  • 3.3.2 Stress ECG Systems 38
  • 3.3.3 Holter ECG Systems 39

4 Segmentation of Asia Pacific Market by Device Modality 40

• 4.1 Market Overview by Device Modality 40
• 4.2 Handheld Device 42
• 4.3 Pen 43
• 4.4 Band 44

5 Segmentation of Asia Pacific Market by End User 45

• 5.1 Market Overview by End User 45
• 5.2 Home-based Users 47
• 5.3 Hospitals 48
• 5.4 Clinics 49
• 5.5 Ambulatory Services 50
• 5.6 Other End Users 51

6 Segmentation of Asia Pacific Market by Distribution Channel 52

• 6.1 Market Overview by Distribution Channel 52
• 6.2 E-commerce 54
• 6.3 Offline Sales 55

7 Asia-Pacific Market 2019-2026 by Country 56

• 7.1 Overview of Asia-Pacific Market 56
• 7.2 Japan 59
• 7.3 China 62
• 7.4 Australia 64
• 7.5 India 66
• 7.6 South Korea 68
• 7.7 Rest of APAC Region 70

8 Competitive Landscape 72

• 8.1 Overview of Key Vendors 72
• 8.2 New Product Launch, Partnership, Investment, and M&A 75
• 8.3 Company Profiles 76

Abbott 76

Aerotel Medical Systems 78

AliveCor 79

Becton Dickinson 80

BPL Medical Technologies 81

Cardiocity Limited 82

CardioComm Solutions 83

GE Healthcare 84

iRhythm Technologies 85

Johnson & Johnson 86

MD Biomedical, Inc. 87

MediBioSense 88

Medtronic 89

Nihon Kohden 90

Omron Healthcare 91

Philips Healthcare 92

Thermo Fisher Scientific 93

Thor Laboratories 94

9 Investing in Asia Pacific Market: Risk Assessment and Management 95

• 9.1 Risk Evaluation of Asia Pacific Market 95
• 9.2 Critical Success Factors (CSFs) 98

Related Reports and Products 101

Asia Pacific wireless electrocardiography market will grow by 8.06% over 2020-2026 with a total addressable market cap of $2.19 billion driven by the rising healthcare expenditure and growing need for ECG devices in the region.
Highlighted with 32 tables and 36 figures, this 101-page report “Asia Pacific Wireless Electrocardiography (ECG) Devices Market 2020-2026 by Product Type, Device Modality, End User, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific wireless electrocardiography market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify Asia Pacific wireless electrocardiography market in every aspect of the classification from perspectives of Product Type, Device Modality, End User, Distribution Channel, and Country.
Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
Monitoring ECG Systems
• Remote Data Monitoring
• Event Monitoring
• Continuous Cardiovascular Monitoring Systems
Diagnostic ECG Systems
• Rest ECG Systems
• Stress ECG Systems
• Holter ECG Systems
Based on Device Modality, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
• Handheld Device
• Pen
• Band
Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
• Home-based Users
• Hospitals
• Clinics
• Ambulatory Services
• Other End Users
Based on Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
• E-commerce
• Offline Sales
Geographically, the following regions together with the listed national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
For each of the five key countries, market analysis and revenue data are available for 2019-2026. The breakdown of major national markets by Product Type, Device Modality, and End User over the years 2019-2026 are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific wireless electrocardiography market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott
Aerotel Medical Systems
AliveCor
Becton Dickinson
BPL Medical Technologies
Cardiocity Limited
CardioComm Solutions
GE Healthcare
iRhythm Technologies
Johnson & Johnson
MD Biomedical, Inc.
MediBioSense
Medtronic
Nihon Kohden
Omron Healthcare
Philips Healthcare
Thermo Fisher Scientific
Thor Laboratories
(Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)